Revero is an AI-powered digital clinic founded in 2019 and based in San Francisco. The company has raised over $6 million from investors including Andreessen Horowitz and Goodwater Capital. It operates a virtual care model designed to address the root causes of autoimmune and chronic metabolic diseases rather than managing symptoms.
The core offering combines clinician-supervised nutrition therapy - primarily a low-carbohydrate diet - with ongoing remote medical support. Patients receive access to medical providers and health coaches, supported by a mobile application that tracks biomarkers daily. Machine learning underpins the personalisation of care plans, with the clinical aim of lowering blood sugar, reducing inflammation, and restoring gut health.
The company's approach integrates several technical capabilities: machine learning algorithms, remote patient monitoring, biomarker tracking via mobile application, and virtual medical care delivery. Revero reports having helped thousands of people to restore their health and live medication-free, though the scale of the patient population and long-term outcomes remain company-claimed metrics.
